PRESS RELEASE
May 05, 2021 - Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
May 05, 2021 - Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
We’ve achieved this distinction because we made a promise to our patients and caregivers to look at things differently.
It is our passion and purpose to continually seek solutions that transform the lives of those living with rare and severe neurological diseases.
Access scientific and clinical information on Greenwich Biosciences products.
Healthcare professionals can find scientific and clinical information about Greenwich Biosciences products and submit medical inquiries for additional information.
Our primary purpose is to make a positive and meaningful difference in the lives of patients and their caregivers.
Greenwich Biosciences puts patients at the center — and at the start.

Become part of a dynamic, cutting-edge pharmaceutical company on the forefront of therapeutic treatment.
You are leaving the website of Greenwich Biosciences, Inc., the US subsidiary of GW Pharmaceuticals plc. This link will take you to a website to which our Privacy Policy does not apply. Greenwich Biosciences, Inc. is not responsible for the information, content or product(s) found on third party websites.
We are closely monitoring our supply chain of EPIDIOLEX® (cannabidiol) and, at this time, do not foresee any supply interruptions in the United States.
At Greenwich Biosciences, our main concern is the well-being of our patients, healthcare partners, and employees. Our hearts and thoughts go out to the people who have been affected. We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients remain consistent.